JPY 1765.0
(2.02%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 373.23 Million | 387.24 Million | 272.49 Million | 185.75 Million | 168.03 Million | 150.24 Million |
Net Income | 473.82 Million | 625.92 Million | 419.32 Million | 304.43 Million | 269.85 Million | 202.44 Million |
Depreciation & Amortization | 4.81 Million | 4.55 Million | 3.93 Million | 3.1 Million | 2.69 Million | 2.62 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -72.39 Million | -52.98 Million | -94.43 Million | -15.95 Million | -18.55 Million | -54.47 Million |
Other non-cash items | -33.01 Million | -190.24 Million | -56.33 Million | -105.82 Million | -85.95 Million | -351 Thousand |
Investing Cash Flow | -13.36 Million | -55.31 Million | -2.09 Million | -9.75 Million | -1.05 Million | -12.6 Million |
Investments in PPE | -3.14 Million | -4.75 Million | -2.09 Million | -6.71 Million | -885 Thousand | -19.46 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -10 Million | -50.4 Million | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -218 Thousand | -158 Thousand | -1 Million | -3.04 Million | -171 Thousand | 6.86 Million |
Financing Cash Flow | -44.07 Million | -201.83 Million | -11.96 Million | 517.74 Million | -44.43 Million | -76.27 Million |
Debt repayment | - | - | - | - | -44.43 Million | -133.39 Million |
Dividends payments | -45.21 Million | -30.45 Million | -24.14 Million | - | - | - |
Common Stock Repurchased | - | -174.87 Million | - | - | - | - |
Common Stock Issuance | - | - | 12.18 Million | 517.64 Million | - | 10.12 Million |
Other Financing Activities | 1.14 Million | 3.49 Million | 13 Million | 109 Thousand | - | 47 Million |
Accounts receivables | -112.44 Million | 31.81 Million | -103.57 Million | -14.99 Million | -15.38 Million | -33.48 Million |
Accounts payables | 34.78 Million | 30.62 Million | 41 Million | 2.64 Million | -21.04 Million | 12.03 Million |
Inventory | 9.61 Million | 1.7 Million | -18.11 Million | 1.69 Million | 10.58 Million | -502 Thousand |
Other working capital | -4.35 Million | -117.13 Million | -13.74 Million | -5.3 Million | 7.29 Million | -53.96 Million |
Cash at beginning of period | 1.4 Billion | 1.27 Billion | 1.01 Billion | 323.17 Million | 200.63 Million | 139.26 Million |
Cash at end of period | 1.72 Billion | 1.4 Billion | 1.27 Billion | 1.01 Billion | 323.17 Million | 200.63 Million |
Capital Expenditure | -3.14 Million | -4.75 Million | -2.09 Million | -6.71 Million | -885 Thousand | -19.46 Million |
Effect of forex changes on cash | - | -1000.00 | - | - | - | - |
Net cash flow / Change in cash | 315.8 Million | 130.09 Million | 258.43 Million | 693.75 Million | 122.53 Million | 61.37 Million |
Free Cash Flow | 370.09 Million | 382.48 Million | 270.4 Million | 179.04 Million | 167.14 Million | 130.78 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 117.88 Million | 100 Million | 473.82 Million | 147 Million | 101 Million | 125 Million |
Depreciation & Amortization | - | - | 4.81 Million | 1.25 Million | 1.24 Million | 1.21 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -72.39 Million | - | - | - |
Other non-cash items | -117.88 Million | -100 Million | -33.01 Million | -147 Million | -101 Million | -125 Million |
Investing Cash Flow | - | - | -13.36 Million | - | - | - |
Investments in PPE | - | - | -3.14 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -10 Million | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -218 Thousand | - | - | - |
Financing Cash Flow | - | - | -44.07 Million | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | -45.21 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 1.14 Million | - | - | - |
Accounts receivables | - | - | -112.44 Million | - | - | - |
Accounts payables | - | - | 34.78 Million | - | - | - |
Inventory | - | - | 9.61 Million | - | - | - |
Other working capital | - | - | -4.35 Million | - | - | - |
Cash at beginning of period | - | - | 1.4 Billion | 1.52 Billion | 1.56 Billion | 1.39 Billion |
Cash at end of period | - | - | 1.72 Billion | 1.72 Billion | 1.52 Billion | 1.56 Billion |
Capital Expenditure | - | - | -3.14 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 315.8 Million | 200.14 Million | -45.4 Million | 171.67 Million |
Free Cash Flow | - | - | 370.09 Million | 2.5 Million | 2.48 Million | 2.42 Million |
3064
MLSUM
BIO
MAZDA
KHAZANCHI
VSSAB-B